NovioSense Announces Positive Clinical Trial Results of Tear Glucose Measurement Technology

NovioSense has demonstrated the measurement of tear glucose in diabetic patients and a close correlation to blood glucose with clinically relevant accuracy. A second, 24-patient study, to validate the use of the new glucose sensor in type 1 diabetic patients is already commencing.

NovioSense BV, a company based in The Netherlands, announced positi (Read more...)

Full Story →